Table 2 Serum concentrations of inflammatory and oxidative stress indices at baseline and post-intervention.
Variables | Time | CP (n = 24) | EP (n = 23) | CE (n = 25) | PP (n = 23) | Between-group difference in change, mean (95% CI)b | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CP vs. EP | CP vs. CE | CP vs. PP | EP vs. CE | EP vs. PP | CE vs. PP | ||||||
Hs-CRP | Before | 9.30 ± 3.19 | 8.66 ± 2.09 | 9.42 ± 2.57 | 8.63 ± 1.45 | 0.50 (−0.34, 1.36) | 0.28 (−0.56, 1.14) | −0.56 (−1.42, 0.28) | −0.21 (−1.07, 0.63) | −1.07 (−1.92, −0.21) | −0.85 (−1.70, −0.01) |
After | 7.31 ± 2.21 | 6.94 ± 1.84 | 6.61 ± 2.58 | 9.11 ± 2.55 | |||||||
MD | −1.99 (−3.72, −0.26) | −1.71 (−2.89, −0.53)a | −2.84 (−4.51, −1.17)a | 0.48 (−0.85, 1.82) | |||||||
TAC | Before | 3.15 ± 1.41 | 2.91 ± 1.22 | 3.36 ± 1.27 | 3.24 ± 1.19 | 0.13 (−0.65, 0.38) | −0.72 (−1.24, −0.20)a | 0.14 (−0.37, 0.66) | −0.85 (−1.37, −0.34)a | 0.01 (−0.50, 0.52) | 0.86 (0.35, 1.38)a |
After | 3.54 ± 1.32 | 3.51 ± 1.39 | 4.78 ± 1.19 | 3.17 ± 1.22 | |||||||
MD | 0.38 (−0.32, 1.09) | 0.59 (−0.25, 1.45) | 1.42 (0.69, 2.16)a | −0.07 (−0.69, 0.55) | |||||||
MDA | Before | 6.00 ± 2.19 | 5.71 ± 1.99 | 6.91 ± 2.62 | 6.47 ± 1.77 | −0.21 (−0.65, 1.08) | 0.27 (−0.59, 1.14) | −0.62 (−1.48, 0.24) | 0.06 (−0.80, 0.92) | −0.83 (−1.70, 0.03) | −0.89 (−1.76, −0.02) |
After | 5.08 ± 2.93 | 5.25 ± 2.35 | 4.60 ± 2.01 | 6.28 ± 1.92 | |||||||
MD | −0.91 (−2.39, 0.56) | −0.45 (−1.84, 0.92) | −2.30 (−3.70, −0.89)a | −0.18 (−1.32, 0.95) | |||||||
